ENT‐1‐targeted MTX‐loaded polymersomes (Gn‐MTX@SS‐Ps) achieve significantly greater tumor shrinkage in mice, reducing tumors by 30% more than nontargeted MTX@SS‐Ps and 75% more than free MTX at the same dosage regimen. Here, SLC29A1 is linked to neoplasm.